CA
NZ
UK
AU
IND
US
Brookdale Senior Living Inc. (NYSE: BKD) shares were trading at USD 9.60 on October 27, 2026, down 1.64%, with a relative volume at time of 3.43. The senior living operator reported September 2026 occupancy on October 8, 2026, after management held its second quarter …
Centene Corporation (NYSE: CNC) shares were trading at USD 69.01 on October 27, 2026, up 1.44%, with a relative volume at time of 3.62. The managed care company filed its 10-Q for the quarter ended September 30, 2026 on October 27, redeemed its remaining …
Climb Bio (NASDAQ: CLYM) shares were trading at USD 10.03 on October 27, 2026, up 13.85%, with a relative volume at time of 8.08. The clinical-stage biotechnology company completed a private placement in April 2026, entered a $100.0 million at-the-market program in June 2026, …
Glaukos Corporation (NYSE: GKOS) shares were trading at USD 183.85 on October 27, 2026, up 3.13%, with a relative volume at time of 3.95. The ophthalmic pharmaceutical and medical technology company received a permanent J-code for Epioxa on April 15, 2026, filed its 10-Q …
HCA Healthcare, Inc. (NYSE: HCA) shares were trading at USD 442.78 on October 27, 2026, down 4.83%, with a relative volume at time of 4.29. The hospital operator reported third quarter 2026 results on October 27, including revenues of $19.849 billion, a quarterly dividend …
IQVIA Holdings Inc. (NYSE: IQV) shares were trading at USD 270.99 on October 27, 2026, down 0.95%, with a relative volume at time of 3.14. The healthcare data and clinical research company reported third-quarter 2026 results on October 27, 2026, raised its full-year 2026 …
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) shares were trading at USD 89.48 on October 27, 2026, up 22.61%, with a relative volume at time of 3.49. The biopharmaceutical company reported third quarter 2026 results on October 27, 2026, raised its 2026 ARCALYST net product …
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) shares were trading at USD 20.74 on October 27, 2026, up 0.88%, with a relative volume at time of 4.69. The clinical-stage company filed its 10-Q for the quarter ended June 30, 2026 on August 11, entered a term …
NeoGenomics, Inc. (NASDAQ: NEO) shares were trading at USD 17.25 on October 27, 2026, up 3.36%, with a relative volume at time of 3.24. On October 5, 2026 the oncology diagnostics company announced an executive and board succession plan, along with preliminary unaudited third …
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) shares were trading at USD 9.02 on October 27, 2026, up 0.75%, with a relative volume at time of 2.98. The clinical-stage oncology company entered a clinical trial collaboration and supply agreement with Bayer on July 7, 2026, for …
Please wait processing your request...